Development
Emergent BioSolutions Inc.
EBS
$6.22
-$0.02-0.32%
NYSE
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 111.70M | 87.80M | 88.60M | 436.10M | 651.10M |
| Total Receivables | 191.00M | 216.50M | 290.10M | 155.90M | 159.20M |
| Inventory | 328.90M | 354.10M | 354.30M | 367.90M | 350.70M |
| Prepaid Expenses | 47.90M | 57.90M | 44.70M | 35.80M | 49.40M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | 4.50M | -- | 225.60M | -- |
| Total Current Assets | 679.50M | 720.80M | 777.70M | 1.22B | 1.21B |
|
|
|||||
| Total Current Assets | 679.50M | 720.80M | 777.70M | 1.22B | 1.21B |
| Net Property, Plant & Equipment | 399.00M | 412.50M | 411.20M | 732.30M | 837.00M |
| Long-term Investments | -- | -- | 218.20M | 218.20M | 218.20M |
| Goodwill | -- | -- | 218.20M | 218.20M | 218.20M |
| Total Other Intangibles | 566.60M | 582.80M | 592.80M | 608.90M | 728.80M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 178.10M | 177.00M | 178.90M | 169.10M | 171.90M |
| Total Assets | 1.82B | 1.89B | 2.18B | 2.95B | 3.17B |
|
|
|||||
| Total Accounts Payable | 112.20M | 112.70M | 108.30M | 124.20M | 103.50M |
| Total Accrued Expenses | 92.70M | 99.50M | 100.80M | 78.10M | 122.20M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 417.20M | 417.10M | 458.80M | 954.10M | 963.10M |
| Total Finance Division Other Current Liabilities | 29.20M | 34.70M | 25.30M | 59.30M | 40.10M |
| Total Other Current Liabilities | 29.20M | 34.70M | 25.30M | 59.30M | 40.10M |
| Total Current Liabilities | 651.30M | 664.00M | 693.20M | 1.22B | 1.23B |
|
|
|||||
| Total Current Liabilities | 651.30M | 664.00M | 693.20M | 1.22B | 1.23B |
| Long-Term Debt | 446.50M | 448.20M | 448.00M | 447.70M | 448.50M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 13.80M | 14.60M | 13.10M | 13.00M | 14.80M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 62.30M | 69.10M | 68.20M | 70.80M | 86.40M |
| Total Liabilities | 1.17B | 1.20B | 1.22B | 1.75B | 1.78B |
|
|
|||||
| Common Stock & APIC | 904.50M | 899.80M | 895.90M | 878.30M | 873.60M |
| Retained Earnings | -21.80M | 27.70M | 289.70M | 551.00M | 738.70M |
| Treasury Stock & Other | -233.40M | -230.30M | -229.30M | -226.70M | -224.60M |
| Total Common Equity | 649.30M | 697.20M | 956.30M | 1.20B | 1.39B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 649.30M | 697.20M | 956.30M | 1.20B | 1.39B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 649.30M | 697.20M | 956.30M | 1.20B | 1.39B |
|
|
|||||